CA2763789A1 - Method and system for analyte data transmission and report generation - Google Patents
Method and system for analyte data transmission and report generation Download PDFInfo
- Publication number
- CA2763789A1 CA2763789A1 CA2763789A CA2763789A CA2763789A1 CA 2763789 A1 CA2763789 A1 CA 2763789A1 CA 2763789 A CA2763789 A CA 2763789A CA 2763789 A CA2763789 A CA 2763789A CA 2763789 A1 CA2763789 A1 CA 2763789A1
- Authority
- CA
- Canada
- Prior art keywords
- data
- medical data
- docking station
- report
- memory
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 239000012491 analyte Substances 0.000 title claims description 69
- 238000000034 method Methods 0.000 title claims description 44
- 230000005540 biological transmission Effects 0.000 title claims description 16
- 238000003032 molecular docking Methods 0.000 claims abstract description 119
- 238000012546 transfer Methods 0.000 claims abstract description 38
- 238000007639 printing Methods 0.000 claims abstract description 27
- 230000015654 memory Effects 0.000 claims description 73
- 230000006854 communication Effects 0.000 claims description 71
- 238000004891 communication Methods 0.000 claims description 69
- 238000012806 monitoring device Methods 0.000 claims description 59
- 238000013523 data management Methods 0.000 claims description 38
- 230000008569 process Effects 0.000 claims description 19
- 230000001413 cellular effect Effects 0.000 claims description 7
- 230000036541 health Effects 0.000 abstract description 22
- 238000007726 management method Methods 0.000 abstract description 19
- 238000012552 review Methods 0.000 abstract description 7
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 53
- 239000008103 glucose Substances 0.000 description 53
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 24
- 206010012601 diabetes mellitus Diseases 0.000 description 23
- 239000008280 blood Substances 0.000 description 20
- 210000004369 blood Anatomy 0.000 description 20
- 238000012545 processing Methods 0.000 description 15
- 238000012544 monitoring process Methods 0.000 description 13
- 102000004877 Insulin Human genes 0.000 description 12
- 108090001061 Insulin Proteins 0.000 description 12
- 238000010586 diagram Methods 0.000 description 12
- 229940125396 insulin Drugs 0.000 description 12
- 238000003860 storage Methods 0.000 description 11
- 229940079593 drug Drugs 0.000 description 9
- 239000003814 drug Substances 0.000 description 9
- 230000008901 benefit Effects 0.000 description 7
- 238000004458 analytical method Methods 0.000 description 6
- 230000008878 coupling Effects 0.000 description 6
- 238000010168 coupling process Methods 0.000 description 6
- 238000005859 coupling reaction Methods 0.000 description 6
- 238000013500 data storage Methods 0.000 description 5
- 238000001802 infusion Methods 0.000 description 5
- 230000000977 initiatory effect Effects 0.000 description 5
- 238000005259 measurement Methods 0.000 description 5
- 238000009877 rendering Methods 0.000 description 5
- 230000006870 function Effects 0.000 description 4
- 230000004044 response Effects 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- 238000012384 transportation and delivery Methods 0.000 description 4
- -1 CK-MB) Chemical compound 0.000 description 3
- 208000017667 Chronic Disease Diseases 0.000 description 3
- 206010067584 Type 1 diabetes mellitus Diseases 0.000 description 3
- 238000004364 calculation method Methods 0.000 description 3
- 235000005911 diet Nutrition 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 235000012054 meals Nutrition 0.000 description 3
- BPYKTIZUTYGOLE-IFADSCNNSA-N Bilirubin Chemical compound N1C(=O)C(C)=C(C=C)\C1=C\C1=C(C)C(CCC(O)=O)=C(CC2=C(C(C)=C(\C=C/3C(=C(C=C)C(=O)N\3)C)N2)CCC(O)=O)N1 BPYKTIZUTYGOLE-IFADSCNNSA-N 0.000 description 2
- 208000013016 Hypoglycemia Diseases 0.000 description 2
- 235000021074 carbohydrate intake Nutrition 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 238000010276 construction Methods 0.000 description 2
- CVSVTCORWBXHQV-UHFFFAOYSA-N creatine Chemical compound NC(=[NH2+])N(C)CC([O-])=O CVSVTCORWBXHQV-UHFFFAOYSA-N 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 230000037213 diet Effects 0.000 description 2
- 238000010017 direct printing Methods 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 238000012377 drug delivery Methods 0.000 description 2
- 235000012631 food intake Nutrition 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 238000013160 medical therapy Methods 0.000 description 2
- 238000002483 medication Methods 0.000 description 2
- 230000005055 memory storage Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 230000000737 periodic effect Effects 0.000 description 2
- ZFXYFBGIUFBOJW-UHFFFAOYSA-N theophylline Chemical compound O=C1N(C)C(=O)N(C)C2=C1NC=N2 ZFXYFBGIUFBOJW-UHFFFAOYSA-N 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 239000004382 Amylase Substances 0.000 description 1
- 102000013142 Amylases Human genes 0.000 description 1
- 108010065511 Amylases Proteins 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 102000011022 Chorionic Gonadotropin Human genes 0.000 description 1
- 108010062540 Chorionic Gonadotropin Proteins 0.000 description 1
- 102000004420 Creatine Kinase Human genes 0.000 description 1
- 108010042126 Creatine kinase Proteins 0.000 description 1
- WDJUZGPOPHTGOT-OAXVISGBSA-N Digitoxin Natural products O([C@H]1[C@@H](C)O[C@@H](O[C@@H]2C[C@@H]3[C@@](C)([C@@H]4[C@H]([C@]5(O)[C@@](C)([C@H](C6=CC(=O)OC6)CC5)CC4)CC3)CC2)C[C@H]1O)[C@H]1O[C@@H](C)[C@H](O[C@H]2O[C@@H](C)[C@@H](O)[C@@H](O)C2)[C@@H](O)C1 WDJUZGPOPHTGOT-OAXVISGBSA-N 0.000 description 1
- LTMHDMANZUZIPE-AMTYYWEZSA-N Digoxin Natural products O([C@H]1[C@H](C)O[C@H](O[C@@H]2C[C@@H]3[C@@](C)([C@@H]4[C@H]([C@]5(O)[C@](C)([C@H](O)C4)[C@H](C4=CC(=O)OC4)CC5)CC3)CC2)C[C@@H]1O)[C@H]1O[C@H](C)[C@@H](O[C@H]2O[C@@H](C)[C@H](O)[C@@H](O)C2)[C@@H](O)C1 LTMHDMANZUZIPE-AMTYYWEZSA-N 0.000 description 1
- CEAZRRDELHUEMR-URQXQFDESA-N Gentamicin Chemical compound O1[C@H](C(C)NC)CC[C@@H](N)[C@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](NC)[C@@](C)(O)CO2)O)[C@H](N)C[C@@H]1N CEAZRRDELHUEMR-URQXQFDESA-N 0.000 description 1
- 229930182566 Gentamicin Natural products 0.000 description 1
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 1
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 1
- 108010072866 Prostate-Specific Antigen Proteins 0.000 description 1
- 102100038358 Prostate-specific antigen Human genes 0.000 description 1
- 102100027378 Prothrombin Human genes 0.000 description 1
- 108010094028 Prothrombin Proteins 0.000 description 1
- 208000017442 Retinal disease Diseases 0.000 description 1
- 206010038923 Retinopathy Diseases 0.000 description 1
- 102000011923 Thyrotropin Human genes 0.000 description 1
- 108010061174 Thyrotropin Proteins 0.000 description 1
- 102000004903 Troponin Human genes 0.000 description 1
- 108090001027 Troponin Proteins 0.000 description 1
- 208000003443 Unconsciousness Diseases 0.000 description 1
- 108010059993 Vancomycin Proteins 0.000 description 1
- OIPILFWXSMYKGL-UHFFFAOYSA-N acetylcholine Chemical compound CC(=O)OCC[N+](C)(C)C OIPILFWXSMYKGL-UHFFFAOYSA-N 0.000 description 1
- 229960004373 acetylcholine Drugs 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 235000019418 amylase Nutrition 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 238000007681 bariatric surgery Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 230000007175 bidirectional communication Effects 0.000 description 1
- 230000002457 bidirectional effect Effects 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 229940107161 cholesterol Drugs 0.000 description 1
- 229940015047 chorionic gonadotropin Drugs 0.000 description 1
- 229960003624 creatine Drugs 0.000 description 1
- 239000006046 creatine Substances 0.000 description 1
- 238000007405 data analysis Methods 0.000 description 1
- 238000013480 data collection Methods 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 229960000648 digitoxin Drugs 0.000 description 1
- WDJUZGPOPHTGOT-XUDUSOBPSA-N digitoxin Chemical compound C1[C@H](O)[C@H](O)[C@@H](C)O[C@H]1O[C@@H]1[C@@H](C)O[C@@H](O[C@@H]2[C@H](O[C@@H](O[C@@H]3C[C@@H]4[C@]([C@@H]5[C@H]([C@]6(CC[C@@H]([C@@]6(C)CC5)C=5COC(=O)C=5)O)CC4)(C)CC3)C[C@@H]2O)C)C[C@@H]1O WDJUZGPOPHTGOT-XUDUSOBPSA-N 0.000 description 1
- 229960005156 digoxin Drugs 0.000 description 1
- LTMHDMANZUZIPE-PUGKRICDSA-N digoxin Chemical compound C1[C@H](O)[C@H](O)[C@@H](C)O[C@H]1O[C@@H]1[C@@H](C)O[C@@H](O[C@@H]2[C@H](O[C@@H](O[C@@H]3C[C@@H]4[C@]([C@@H]5[C@H]([C@]6(CC[C@@H]([C@@]6(C)[C@H](O)C5)C=5COC(=O)C=5)O)CC4)(C)CC3)C[C@@H]2O)C)C[C@@H]1O LTMHDMANZUZIPE-PUGKRICDSA-N 0.000 description 1
- LTMHDMANZUZIPE-UHFFFAOYSA-N digoxine Natural products C1C(O)C(O)C(C)OC1OC1C(C)OC(OC2C(OC(OC3CC4C(C5C(C6(CCC(C6(C)C(O)C5)C=5COC(=O)C=5)O)CC4)(C)CC3)CC2O)C)CC1O LTMHDMANZUZIPE-UHFFFAOYSA-N 0.000 description 1
- 230000009977 dual effect Effects 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 238000013213 extrapolation Methods 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 239000000446 fuel Substances 0.000 description 1
- 229960002518 gentamicin Drugs 0.000 description 1
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 1
- 239000000122 growth hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 201000001421 hyperglycemia Diseases 0.000 description 1
- 230000002218 hypoglycaemic effect Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 208000017169 kidney disease Diseases 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 230000003278 mimic effect Effects 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 201000001119 neuropathy Diseases 0.000 description 1
- 230000007823 neuropathy Effects 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 208000033808 peripheral neuropathy Diseases 0.000 description 1
- 150000002978 peroxides Chemical class 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 229940039716 prothrombin Drugs 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 229960000278 theophylline Drugs 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 230000001960 triggered effect Effects 0.000 description 1
- 208000001072 type 2 diabetes mellitus Diseases 0.000 description 1
- 229960003165 vancomycin Drugs 0.000 description 1
- MYPYJXKWCTUITO-LYRMYLQWSA-N vancomycin Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=C2C=C3C=C1OC1=CC=C(C=C1Cl)[C@@H](O)[C@H](C(N[C@@H](CC(N)=O)C(=O)N[C@H]3C(=O)N[C@H]1C(=O)N[C@H](C(N[C@@H](C3=CC(O)=CC(O)=C3C=3C(O)=CC=C1C=3)C(O)=O)=O)[C@H](O)C1=CC=C(C(=C1)Cl)O2)=O)NC(=O)[C@@H](CC(C)C)NC)[C@H]1C[C@](C)(N)[C@H](O)[C@H](C)O1 MYPYJXKWCTUITO-LYRMYLQWSA-N 0.000 description 1
- MYPYJXKWCTUITO-UHFFFAOYSA-N vancomycin Natural products O1C(C(=C2)Cl)=CC=C2C(O)C(C(NC(C2=CC(O)=CC(O)=C2C=2C(O)=CC=C3C=2)C(O)=O)=O)NC(=O)C3NC(=O)C2NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(CC(C)C)NC)C(O)C(C=C3Cl)=CC=C3OC3=CC2=CC1=C3OC1OC(CO)C(O)C(O)C1OC1CC(C)(N)C(O)C(C)O1 MYPYJXKWCTUITO-UHFFFAOYSA-N 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- PJVWKTKQMONHTI-UHFFFAOYSA-N warfarin Chemical compound OC=1C2=CC=CC=C2OC(=O)C=1C(CC(=O)C)C1=CC=CC=C1 PJVWKTKQMONHTI-UHFFFAOYSA-N 0.000 description 1
- 229960005080 warfarin Drugs 0.000 description 1
- 230000004580 weight loss Effects 0.000 description 1
Classifications
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
- G16H20/10—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients
- G16H20/17—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients delivered via infusion or injection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/0002—Remote monitoring of patients using telemetry, e.g. transmission of vital signals via a communication network
- A61B5/0015—Remote monitoring of patients using telemetry, e.g. transmission of vital signals via a communication network characterised by features of the telemetry system
- A61B5/0022—Monitoring a patient using a global network, e.g. telephone networks, internet
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue
- A61B5/14532—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue for measuring glucose, e.g. by tissue impedance measurement
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue
- A61B5/14546—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue for measuring analytes not otherwise provided for, e.g. ions, cytochromes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
- A61M5/142—Pressure infusion, e.g. using pumps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
- A61M5/168—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body
- A61M5/172—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body electrical or electronic
- A61M5/1723—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body electrical or electronic using feedback of body parameters, e.g. blood-sugar, pressure
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H15/00—ICT specially adapted for medical reports, e.g. generation or transmission thereof
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H40/00—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices
- G16H40/60—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices
- G16H40/67—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices for remote operation
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H70/00—ICT specially adapted for the handling or processing of medical references
- G16H70/20—ICT specially adapted for the handling or processing of medical references relating to practices or guidelines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B2560/00—Constructional details of operational features of apparatus; Accessories for medical measuring apparatus
- A61B2560/04—Constructional details of apparatus
- A61B2560/0456—Apparatus provided with a docking unit
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B2562/00—Details of sensors; Constructional details of sensor housings or probes; Accessories for sensors
- A61B2562/02—Details of sensors specially adapted for in-vivo measurements
- A61B2562/0295—Strip shaped analyte sensors for apparatus classified in A61B5/145 or A61B5/157
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/33—Controlling, regulating or measuring
- A61M2205/3303—Using a biosensor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/35—Communication
- A61M2205/3546—Range
- A61M2205/3553—Range remote, e.g. between patient's home and doctor's office
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2230/00—Measuring parameters of the user
- A61M2230/20—Blood composition characteristics
- A61M2230/201—Glucose concentration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2230/00—Measuring parameters of the user
- A61M2230/20—Blood composition characteristics
- A61M2230/205—Blood composition characteristics partial oxygen pressure (P-O2)
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medical Informatics (AREA)
- Biomedical Technology (AREA)
- Physics & Mathematics (AREA)
- Animal Behavior & Ethology (AREA)
- Heart & Thoracic Surgery (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Primary Health Care (AREA)
- Biophysics (AREA)
- Pathology (AREA)
- Molecular Biology (AREA)
- Surgery (AREA)
- Optics & Photonics (AREA)
- Hematology (AREA)
- Vascular Medicine (AREA)
- Anesthesiology (AREA)
- Computer Networks & Wireless Communication (AREA)
- Emergency Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Business, Economics & Management (AREA)
- General Business, Economics & Management (AREA)
- Bioethics (AREA)
- Diabetes (AREA)
- Measuring And Recording Apparatus For Diagnosis (AREA)
- Medical Treatment And Welfare Office Work (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US26284909P | 2009-11-19 | 2009-11-19 | |
| US61/262,849 | 2009-11-19 | ||
| PCT/US2010/057516 WO2011063294A2 (en) | 2009-11-19 | 2010-11-19 | Method and system for analyte data transmission and report generation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA2763789A1 true CA2763789A1 (en) | 2011-05-26 |
Family
ID=43646039
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA2763789A Abandoned CA2763789A1 (en) | 2009-11-19 | 2010-11-19 | Method and system for analyte data transmission and report generation |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US20110119080A1 (enExample) |
| EP (1) | EP2502171A2 (enExample) |
| JP (1) | JP5592499B2 (enExample) |
| CN (1) | CN102473199A (enExample) |
| AU (1) | AU2010321758A1 (enExample) |
| BR (1) | BRPI1012947A2 (enExample) |
| CA (1) | CA2763789A1 (enExample) |
| WO (1) | WO2011063294A2 (enExample) |
Families Citing this family (52)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2960415B1 (fr) * | 2010-05-27 | 2012-12-28 | Nestis | Generateur de jets pulses haute pression d'un liquide en vue d'applications medicales et chirugicales |
| KR101817593B1 (ko) * | 2010-12-09 | 2018-01-12 | 에스프린팅솔루션 주식회사 | 화상형성장치 및 호스트 장치와 그 연결 방법 |
| US9760679B2 (en) | 2011-02-11 | 2017-09-12 | Abbott Diabetes Care Inc. | Data synchronization between two or more analyte detecting devices in a database |
| US9913599B2 (en) | 2011-02-11 | 2018-03-13 | Abbott Diabetes Care Inc. | Software applications residing on handheld analyte determining devices |
| US20140088392A1 (en) | 2011-02-11 | 2014-03-27 | Abbott Diabetes Care Inc. | Feedback from Cloud or HCP to Payer or Patient via Meter or Cell Phone |
| US8485439B2 (en) * | 2011-10-11 | 2013-07-16 | Solomon Systems, Inc. | System for providing identification and information, and for scheduling alerts |
| US9183720B2 (en) * | 2012-01-14 | 2015-11-10 | DocView Solutions LLC | Interactive medical device monitoring and management system |
| US9076315B2 (en) * | 2012-01-14 | 2015-07-07 | DocView Solutions LLC | Interactive remote disease monitoring and management system |
| US20130183923A1 (en) * | 2012-01-16 | 2013-07-18 | Charles Cameron Brackett | Field nurse notification |
| US10453573B2 (en) | 2012-06-05 | 2019-10-22 | Dexcom, Inc. | Dynamic report building |
| WO2014058993A2 (en) * | 2012-10-12 | 2014-04-17 | Becton, Dickinson And Company | Case with embedded electronics to provide interface between glucose sensor and smartphone |
| US9730620B2 (en) | 2012-12-31 | 2017-08-15 | Dexcom, Inc. | Remote monitoring of analyte measurements |
| US9585563B2 (en) | 2012-12-31 | 2017-03-07 | Dexcom, Inc. | Remote monitoring of analyte measurements |
| TWI512665B (zh) * | 2013-01-18 | 2015-12-11 | Kuo Yuan Chang | 病房雲端系統 |
| US9436933B2 (en) * | 2013-01-24 | 2016-09-06 | Exaktime Innovations, Inc. | Wireless time attendance system and method |
| EP2763065A1 (en) * | 2013-01-31 | 2014-08-06 | Sensirion AG | Method and system for identifying a fluid sample |
| KR20150133716A (ko) * | 2013-03-29 | 2015-11-30 | 소니 주식회사 | 혈액 상태 평가 장치, 혈액 상태 평가 시스템, 혈액 상태 평가 방법 및 프로그램 |
| CN103190915A (zh) * | 2013-04-03 | 2013-07-10 | 无锡市崇安区科技创业服务中心 | 一种血糖检测仪 |
| US9870447B2 (en) * | 2013-04-26 | 2018-01-16 | Roche Diabetes Care, Inc. | Medical data transfer component |
| WO2015055715A1 (en) | 2013-10-16 | 2015-04-23 | Roche Diagnostics Gmbh | Communication interface clip for a handheld medical device |
| EP2894581A1 (en) * | 2014-01-13 | 2015-07-15 | Ares Trading S.A. | Medical device connection station |
| WO2015107681A1 (ja) * | 2014-01-17 | 2015-07-23 | 任天堂株式会社 | 情報処理システム、情報処理サーバ、情報処理プログラム、および情報提供方法 |
| MX387194B (es) * | 2014-06-03 | 2025-03-18 | Amgen Inc | Sistemas y metodos para procesar de manera remota datos recolectados por un dispositivo de suministro de farmaco. |
| US11974847B2 (en) | 2014-08-07 | 2024-05-07 | Nintendo Co., Ltd. | Information processing system, information processing device, storage medium storing information processing program, and information processing method |
| US10971260B2 (en) | 2014-09-14 | 2021-04-06 | Becton, Dickinson And Company | System and method for capturing dose information |
| US10704944B2 (en) | 2014-09-14 | 2020-07-07 | Becton, Dickinson And Company | System and method for capturing dose information |
| US9892628B2 (en) | 2014-10-14 | 2018-02-13 | Logitech Europe S.A. | Method of controlling an electronic device |
| JP6667240B2 (ja) * | 2015-07-31 | 2020-03-18 | キヤノン株式会社 | 装置、方法、システム及びプログラム。 |
| US10734102B2 (en) | 2015-07-31 | 2020-08-04 | Canon Kabushiki Kaisha | Apparatus, method, system, and program for creating and displaying medical reports |
| US11399721B2 (en) | 2015-12-28 | 2022-08-02 | Dexcom, Inc. | Systems and methods for remote and host monitoring communications |
| US10328204B2 (en) * | 2016-05-02 | 2019-06-25 | Dexcom, Inc. | System and method for providing alerts optimized for a user |
| CN106379057A (zh) * | 2016-08-29 | 2017-02-08 | 合肥菲力姆数码科技有限公司 | 医用自助取片机用的喷墨打印装置 |
| US20180137252A1 (en) * | 2016-11-11 | 2018-05-17 | Medtronic Minimed, Inc. | Patient monitoring systems and methods with event log integration |
| EP3618712A1 (en) * | 2017-05-03 | 2020-03-11 | Abbott Diabetes Care Inc. | Systems, devices, and methods with duration-based adjustment of sensor data |
| CN110944689B (zh) | 2017-06-07 | 2022-12-09 | 施菲姆德控股有限责任公司 | 血管内流体运动设备、系统和使用方法 |
| JP6883487B2 (ja) * | 2017-08-08 | 2021-06-09 | 京セラ株式会社 | 充電台、コミュニケーションシステムおよびプログラム |
| JP6883485B2 (ja) * | 2017-07-27 | 2021-06-09 | 京セラ株式会社 | 携帯端末およびプログラム |
| US11380319B2 (en) | 2017-07-24 | 2022-07-05 | Kyocera Corporation | Charging stand, mobile terminal, communication system, method, and program |
| CN110021395A (zh) * | 2017-07-25 | 2019-07-16 | 广州康昕瑞基因健康科技有限公司 | 医学报告分布式生成方法和系统 |
| EP3710076B1 (en) | 2017-11-13 | 2023-12-27 | Shifamed Holdings, LLC | Intravascular fluid movement devices, systems, and methods of use |
| WO2019152875A1 (en) | 2018-02-01 | 2019-08-08 | Shifamed Holdings, Llc | Intravascular blood pumps and methods of use and manufacture |
| WO2020028537A1 (en) | 2018-07-31 | 2020-02-06 | Shifamed Holdings, Llc | Intravascaular blood pumps and methods of use |
| US12220570B2 (en) | 2018-10-05 | 2025-02-11 | Shifamed Holdings, Llc | Intravascular blood pumps and methods of use |
| EP3996797A4 (en) | 2019-07-12 | 2023-08-02 | Shifamed Holdings, LLC | INTRAVASCULAR BLOOD PUMPS AND METHOD OF USE AND METHOD OF MAKING |
| US11654275B2 (en) | 2019-07-22 | 2023-05-23 | Shifamed Holdings, Llc | Intravascular blood pumps with struts and methods of use and manufacture |
| EP4010046A4 (en) | 2019-08-07 | 2023-08-30 | Calomeni, Michael | Catheter blood pumps and collapsible pump housings |
| JP7432328B2 (ja) * | 2019-09-12 | 2024-02-16 | 株式会社トプコン | 医療システム |
| WO2021062260A1 (en) | 2019-09-25 | 2021-04-01 | Shifamed Holdings, Llc | Catheter blood pumps and collapsible blood conduits |
| WO2021062270A1 (en) | 2019-09-25 | 2021-04-01 | Shifamed Holdings, Llc | Catheter blood pumps and collapsible pump housings |
| WO2021062265A1 (en) | 2019-09-25 | 2021-04-01 | Shifamed Holdings, Llc | Intravascular blood pump systems and methods of use and control thereof |
| WO2021119478A1 (en) | 2019-12-11 | 2021-06-17 | Shifamed Holdings, Llc | Descending aorta and vena cava blood pumps |
| WO2021248893A1 (zh) * | 2020-06-12 | 2021-12-16 | 深圳迈瑞生物医疗电子股份有限公司 | 用于处理监控信息的中央站及其对监控信息的处理方法 |
Family Cites Families (36)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2410108A (en) | 1944-09-15 | 1946-10-29 | Socony Vacuum Oil Co Inc | Alkylation |
| US5997476A (en) * | 1997-03-28 | 1999-12-07 | Health Hero Network, Inc. | Networked system for interactive communication and remote monitoring of individuals |
| US6175752B1 (en) | 1998-04-30 | 2001-01-16 | Therasense, Inc. | Analyte monitoring device and methods of use |
| US6602469B1 (en) * | 1998-11-09 | 2003-08-05 | Lifestream Technologies, Inc. | Health monitoring and diagnostic device and network-based health assessment and medical records maintenance system |
| US6454708B1 (en) * | 1999-04-15 | 2002-09-24 | Nexan Limited | Portable remote patient telemonitoring system using a memory card or smart card |
| JP3449958B2 (ja) * | 2000-01-18 | 2003-09-22 | 理想科学工業株式会社 | 印刷システム、印刷方法および印刷プログラムを格納したコンピュータ読取り可能な記録媒体 |
| US7016062B2 (en) * | 2000-11-30 | 2006-03-21 | Ricoh Company, Ltd. | Apparatus, method and system for printing from a wireless mobile device over the internet |
| US6648823B2 (en) * | 2001-07-31 | 2003-11-18 | Medtronic, Inc. | Method and system of follow-up support for a medical device |
| JP2003067651A (ja) * | 2001-08-30 | 2003-03-07 | Seiko Epson Corp | デジタルコンテンツ提供システム，デジタルコンテンツ提供方法，サーバ装置及びデジタルコンテンツ提供サーバプログラム |
| DE10156215A1 (de) * | 2001-11-15 | 2003-06-12 | Siemens Ag | Verfahren zur Verarbeitung medizinisch relevanter Daten |
| JP2004158015A (ja) * | 2001-11-30 | 2004-06-03 | Hitachi Ltd | 申請書の処理システム及び処理システムに用いられるプログラム |
| US7945846B2 (en) * | 2002-09-06 | 2011-05-17 | Oracle International Corporation | Application-specific personalization for data display |
| JP4309111B2 (ja) * | 2002-10-02 | 2009-08-05 | 株式会社スズケン | 健康管理システム、活動状態測定装置及びデータ処理装置 |
| CA2443792A1 (en) * | 2002-10-08 | 2004-04-08 | Bayer Healthcare Llc | Method and systems for data management in patient diagnoses and treatment |
| JP2004280223A (ja) * | 2003-03-13 | 2004-10-07 | Ricoh Co Ltd | コンテンツ出力課金システムおよびその方法並びにプログラムおよび記録媒体 |
| US8066639B2 (en) * | 2003-06-10 | 2011-11-29 | Abbott Diabetes Care Inc. | Glucose measuring device for use in personal area network |
| US20050055243A1 (en) * | 2003-06-30 | 2005-03-10 | Dave Arndt | Method and apparatus for managing data received from a medical device |
| RU2006144463A (ru) * | 2004-05-14 | 2008-06-20 | БАЙЕР ХЕЛТКЭР ЭлЭлСи (US) | Способ и устройство для осуществления загрузки данных пациента для нескольких разнотипных измерителей |
| WO2005119524A2 (en) * | 2004-06-04 | 2005-12-15 | Therasense, Inc. | Diabetes care host-client architecture and data management system |
| US20050273365A1 (en) * | 2004-06-04 | 2005-12-08 | Agfa Corporation | Generalized approach to structured medical reporting |
| US20070060979A1 (en) * | 2004-06-10 | 2007-03-15 | Ndi Medical, Llc | Implantable pulse generator systems and methods for providing functional and / or therapeutic stimulation of muscles and / or nerves and / or central nervous system tissue |
| US9820658B2 (en) * | 2006-06-30 | 2017-11-21 | Bao Q. Tran | Systems and methods for providing interoperability among healthcare devices |
| US20080084578A1 (en) * | 2004-12-07 | 2008-04-10 | Airprint Networks, Inc. | Quality of service methods and systems for mobile printing |
| US8306831B2 (en) * | 2005-01-10 | 2012-11-06 | International Business Machines Corporation | Systems with message integration for data exchange, collection, monitoring and/or alerting |
| JP2008526443A (ja) * | 2005-01-13 | 2008-07-24 | ウェルチ・アリン・インコーポレーテッド | 生命兆候モニタ |
| US20080281298A1 (en) * | 2005-02-07 | 2008-11-13 | Andersen David R | Electronic support system for biological data sensor |
| US20070033074A1 (en) * | 2005-06-03 | 2007-02-08 | Medtronic Minimed, Inc. | Therapy management system |
| WO2007112034A2 (en) * | 2006-03-23 | 2007-10-04 | Becton, Dickinson And Company | System and methods for improved diabetes data management and use |
| JP2009531779A (ja) * | 2006-03-24 | 2009-09-03 | インテリドット コーポレーション | 医療ワークフローシステムにおける電子データの取り込み |
| CN101528118A (zh) * | 2006-11-03 | 2009-09-09 | Ric投资有限责任公司 | 患者信息管理系统 |
| JP4400658B2 (ja) * | 2007-08-28 | 2010-01-20 | コニカミノルタビジネステクノロジーズ株式会社 | 画像形成システム、画像形成方法、およびそれらに向けられた情報処理装置 |
| US20090150771A1 (en) * | 2007-12-07 | 2009-06-11 | Roche Diagnostics Operations, Inc. | System and method for reporting medical information |
| US20090164251A1 (en) * | 2007-12-19 | 2009-06-25 | Abbott Diabetes Care, Inc. | Method and apparatus for providing treatment profile management |
| CN101464927B (zh) * | 2008-07-11 | 2013-05-08 | 理康互联科技(北京)有限公司 | 医疗数据传输处理系统和方法 |
| US8453053B2 (en) * | 2009-03-06 | 2013-05-28 | Ecava Sdn. Bhd. | Rapid software report development tool with auto database handling and menu tool-bar plug-in for application report access |
| WO2010138874A1 (en) * | 2009-05-29 | 2010-12-02 | Abbott Diabetes Care Inc. | Integrated report generation of medical data with varying levels of information |
-
2010
- 2010-11-19 US US12/950,945 patent/US20110119080A1/en not_active Abandoned
- 2010-11-19 CN CN2010800257453A patent/CN102473199A/zh active Pending
- 2010-11-19 CA CA2763789A patent/CA2763789A1/en not_active Abandoned
- 2010-11-19 WO PCT/US2010/057516 patent/WO2011063294A2/en not_active Ceased
- 2010-11-19 JP JP2012540113A patent/JP5592499B2/ja not_active Expired - Fee Related
- 2010-11-19 EP EP10785275A patent/EP2502171A2/en not_active Withdrawn
- 2010-11-19 AU AU2010321758A patent/AU2010321758A1/en not_active Abandoned
- 2010-11-19 BR BRPI1012947-2A patent/BRPI1012947A2/pt not_active IP Right Cessation
-
2016
- 2016-09-23 US US15/274,694 patent/US20170007762A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| CN102473199A (zh) | 2012-05-23 |
| AU2010321758A1 (en) | 2011-12-22 |
| JP5592499B2 (ja) | 2014-09-17 |
| EP2502171A2 (en) | 2012-09-26 |
| US20110119080A1 (en) | 2011-05-19 |
| WO2011063294A2 (en) | 2011-05-26 |
| BRPI1012947A2 (pt) | 2018-01-16 |
| JP2013511780A (ja) | 2013-04-04 |
| WO2011063294A3 (en) | 2011-07-14 |
| US20170007762A1 (en) | 2017-01-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20170007762A1 (en) | Infusion of insulin into a patient and diabetes mellitus medical methods based on the patients monitored analyte concentration | |
| KR101285520B1 (ko) | 만성 질병을 가진 환자의 진단 또는 치료 지원을 위한 구조화된 테스팅 방법 및 그 디바이스 | |
| US10733154B2 (en) | Management method and system for implementation, execution, data collection, and data analysis of a structured collection procedure which runs on a collection device | |
| EP3889965B1 (en) | Management method and system for implementation, execution, data collection, and data analysis of a structured collection procedure which runs on a device | |
| US9339219B2 (en) | Devices, systems, and methods related to analyte monitoring and management | |
| US8766803B2 (en) | Dynamic data collection | |
| US8755938B2 (en) | Systems and methods for handling unacceptable values in structured collection protocols | |
| US20180137252A1 (en) | Patient monitoring systems and methods with event log integration | |
| US20180137938A1 (en) | Patient monitoring systems and methods with automated display toggling | |
| US20100305965A1 (en) | Integrated report generation of medical data with varying levels of information | |
| EP2723233B1 (en) | Management method and system for implementation, execution, data collection, and data analysis of a structured collection procedure which runs on a collection device | |
| US20120089893A1 (en) | Management Method And System For Implementation, Execution, Data Collection, and Data Analysis Of A Structured Collection Procedure Which Runs On A Collection Device | |
| JP2012507309A (ja) | 分析物測定及び管理装置並びに関連した方法 | |
| Vigersky et al. | A wireless diabetes management and communication system | |
| HK1194166B (zh) | 动态数据收集 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request |
Effective date: 20151116 |
|
| FZDE | Discontinued |
Effective date: 20171121 |